↓ Skip to main content

COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function

Overview of attention for article published in BMC Cancer, August 2010
Altmetric Badge

Citations

dimensions_citation
242 Dimensions

Readers on

mendeley
131 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
Published in
BMC Cancer, August 2010
DOI 10.1186/1471-2407-10-464
Pubmed ID
Authors

Joris D Veltman, Margaretha EH Lambers, Menno van Nimwegen, Rudi W Hendriks, Henk C Hoogsteden, Joachim GJV Aerts, Joost PJJ Hegmans

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
China 1 <1%
Germany 1 <1%
Unknown 129 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 18%
Researcher 23 18%
Student > Master 18 14%
Student > Bachelor 11 8%
Student > Doctoral Student 10 8%
Other 24 18%
Unknown 22 17%
Readers by discipline Count As %
Medicine and Dentistry 36 27%
Agricultural and Biological Sciences 28 21%
Immunology and Microbiology 12 9%
Biochemistry, Genetics and Molecular Biology 11 8%
Engineering 4 3%
Other 14 11%
Unknown 26 20%